Spire Wealth Management’s Twist Bioscience TWST Stock Holding History

Spire Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.09K	Hold	30	–	–	﹤0.01%	1917
2026 Q1	$1.43K	Hold	30	–	–	﹤0.01%	2091
2025 Q4	$952	Hold	30	–	–	﹤0.01%	2202
2025 Q3	$844	Hold	30	–	–	﹤0.01%	2298
2025 Q2	$1.1K	Hold	30	–	–	﹤0.01%	2265
2025 Q1	$1.18K	Hold	30	–	–	﹤0.01%	2362
2024 Q4	$1.39K	Hold	30	–	–	﹤0.01%	2316
2024 Q3	$1.35K	Hold	30	–	–	﹤0.01%	2060
2024 Q2	$1.48K	Hold	30	–	–	﹤0.01%	2059
2024 Q1	$1.03K	Hold	30	–	–	﹤0.01%	2201
2023 Q4	$1.01K	Hold	30	–	–	﹤0.01%	2264
2023 Q3	$608	Hold	30	–	–	﹤0.01%	2326
2023 Q2	$614	Buy	+30	New	+$449	﹤0.01%	2361
2023 Q1	–	Sell	-30	Closed	-$1K	–	2599
2022 Q4	$1K	Hold	30	–	–	﹤0.01%	2259
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	2143
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	2584
2022 Q1	$1K	Sell	30 -200	-87%	-$11.1K	﹤0.01%	2485
2021 Q4	$18K	Buy	230 +200	+667%	+$20.5K	﹤0.01%	2165
2021 Q3	$3K	Hold	30	–	–	﹤0.01%	2420
2021 Q2	$4K	Hold	30	–	–	﹤0.01%	2381
2021 Q1	$4K	Buy	+30	New	+$4.56K	﹤0.01%	2714

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Spire Wealth Management's TWST Position: Q2 2026 in Review

Spire Wealth Management held its Twist Bioscience (TWST) position steady in Q2 2026 at 30 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Spire Wealth Management first reported a position in TWST in Q1 2021 and has held it in 21 quarters since. The position peaked at $18K in Q4 2021. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Spire Wealth Management held 30 shares of Twist Bioscience worth $3.09K as of Q2 2026.
Spire Wealth Management left its Twist Bioscience share count unchanged in Q2 2026.
Twist Bioscience made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1917 holding.
Spire Wealth Management first reported a position in Twist Bioscience in Q1 2021 and has held it in 21 quarters since.
Spire Wealth Management's Twist Bioscience position peaked at $18K in Q4 2021.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.